Press release
Long Term Investors in shares of Metagenomi, Inc. (NASDAQ: MGX) should contact the Shareholders Foundation in connection with Investigation of potential Wrongdoing
An investigation on behalf of current long term investors in Metagenomi, Inc. (NASDAQ: MGX) shares.
Investors who are current long term investors in Metagenomi, Inc. (NASDAQ: MGX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: MGX stocks follows a lawsuit filed against Metagenomi, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: MGX stocks, concerns whether certain Metagenomi, Inc. directors are liable in connection with the allegations made in that lawsuit.
According to that complaint filed in the U.S. District Court for the Northern District of California the plaintiff alleges that the Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. The action seeks to compensate the Class members and recover the damages they sustained because of Defendants' allegedly false and misleading statements.
Those who purchased shares of Metagenomi, Inc. (NASDAQ: MGX) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Long Term Investors in shares of Metagenomi, Inc. (NASDAQ: MGX) should contact the Shareholders Foundation in connection with Investigation of potential Wrongdoing here
News-ID: 3940281 • Views: …
More Releases from Shareholders Foundation
SES AI Corporation (NYSE: SES) Investor Alert: Deadline in Lawsuit on June 26, 2 …
A deadline is coming up on June 26, 2026 in the lawsuit filed for certain investors of SES AI Corporation (NYSE: SES) over alleged securities laws violations by SES AI Corporation.
Investors who purchased shares of SES AI Corporation (NYSE: SES) have certain options and there are strict and short deadlines running. Deadline: June 26, 2026. SES AI Corporation (NYSE: SES) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call…
Medpace Holdings, Inc. (NASDAQ: MEDP) Investor Alert: Deadline in Lawsuit on Jun …
A deadline is coming up on June 8, 2026 in the lawsuit filed for certain investors of Medpace Holdings, Inc. (NASDAQ: MEDP) over alleged securities laws violations by Medpace Holdings, Inc. (NASDAQ: MEDP).
Investors who purchased shares of Medpace Holdings, Inc. (NASDAQ: MEDP) have certain options and there are strict and short deadlines running. Deadline: June 8, 2026. Medpace Holdings, Inc. (NASDAQ: MEDP) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Lawsuit filed for Investors who lost money with shares of Enphase Energy, Inc. ( …
An investor, who purchased shares of Enphase Energy, Inc. (NASDAQ: ENPH), filed a lawsuit over alleged violations of Federal Securities Laws by Enphase Energy, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Enphase Energy, Inc. (NASDAQ: ENPH) have certain options and for certain investors are short and strict deadlines running. Deadline: April 20, 2026. NASDAQ: ENPH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Investigation announced for Long-Term Investors in shares of Fiserv, Inc. (NYSE: …
An investigation was announced for current long-term investors in shares of Fiserv, Inc. (NYSE: FI) concerning potential breaches of fiduciary duties by certain directors and officers of Fiserv, Inc.
Investors who are current long term investors in Fiserv, Inc. (NYSE: FI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
More Releases for Metagenomi
Hemophilia Clinical Trial Pipeline Analysis: 20+ Key Companies Advancing the Fut …
DelveInsight's Hemophilia Pipeline Insight 2026 report provides comprehensive global coverage of available, marketed, and pipeline Hemophilia therapies in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the Hemophilia pipeline domain.
Key takeaways from the Hemophilia Clinical Trial Landscape Report
• DelveInsight's Hemophilia pipeline report depicts a robust space with 20+ active players working to develop 25+ pipeline therapies for Hemophilia treatment.
• Key…
Future Prospects: Key Trends Shaping the Base-Editing Tools Market Until 2030
The base-editing tools market is poised for remarkable expansion in the coming years as advancements in gene-editing technology gain momentum. This market's growth is driven by increasing applications in precision medicine, agriculture, and biotechnology, alongside innovations that are transforming how genetic modifications are performed and analyzed. Let's delve deeper into the current market landscape, key players, growth drivers, trends, and segmentation details shaping this exciting field.
Forecasted Expansion of the Base-Editing…
Cell Engineering Service Market Set to Grow Steadily Through 2025, Key Trends, R …
QY Research has recently published a research report titled, "Global Cell Engineering Service Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031", assessing various factors impacting its trajectory. The research study offers deep evaluation of the global Cell Engineering Service market and helps market participants to gain a strong foothold in the industry. It sheds light on critical market dynamics such as drivers, restraints, trends, and opportunities to help…
Investigation announced for Long Term Investors in shares of Metagenomi, Inc. (N …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Metagenomi, Inc.
Investors who are current long term investors in Metagenomi, Inc. (NASDAQ: MGX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: MGX stocks follows a lawsuit filed against Metagenomi, Inc. over…
Lawsuit filed for Investors who lost money with shares of Metagenomi, Inc. (NASD …
An investor, who purchased shares of Metagenomi, Inc. (NASDAQ: MGX), filed a lawsuit over alleged violations of Federal Securities Laws by Metagenomi, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Metagenomi, Inc. (NASDAQ: MGX) have certain options and for certain investors are short and strict deadlines running. Deadline: November 25, 2024. NASDAQ: MGX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
Lawsuit filed for Investors who lost money with Metagenomi, Inc. (NASDAQ: MGX) i …
An investor, who purchased shares of Metagenomi, Inc. (NASDAQ: MGX), filed a lawsuit over alleged violations of Federal Securities Laws by Metagenomi, Inc. in connection with certain allegedly false and misleading statements made between February 9 and 13, 2024.
Investors who purchased a significant amount of shares of Metagenomi, Inc. (NASDAQ: MGX) between February 9 and 13, 2024, have certain options and for certain investors are short and strict deadlines running.…
